News
Stay Ahead with the Latest Updates from InnoStrat
Welcome to our Newsroom — your source for the latest updates from InnoStrat.
Here, we share news about company milestones, new team members, thought leadership, client achievements, and strategic insights from the world of clinical, medical, and commercial innovation.
InnoStrat Heads to EASD 2025: Strategic Insights for Medical Affairs Leaders
11 September 2025
InnoStrat co-founder Jan Kildeskov and partner Henrik Schou will be attending the European Association for the Study of Diabetes (EASD) Annual Meeting in Vienna next week, bringing decades of expertise in medical affairs strategy and commercial innovation to one of Europe’s most influential diabetes conferences.
InnoStrat Secures EIFO Funding to Accelerate Life Science Consulting Expansion
24 July 2025
InnoStrat has secured funding from Denmark’s Export and Investment Fund (EIFO) to expand its consulting capabilities and global reach within the life science sector.
Celebrating 5 Years of InnoStrat!
22 June 2025
We’re celebrating 5 incredible years of InnoStrat — and we’ve just moved into new offices to make room for our growing team!
A Deepening Role in Strategic Support for Medical Affairs Leaders
24 June 2025
Fresh insights from Boston and Chicago: GLP-1s, obesity, and diabetes dominate the biotech agenda — and the need for strong Medical Affairs strategy has never been greater. InnoStrat supports biotechs in building medical functions, shaping scientific narratives, and accelerating uptake in Europe.
Ready to launch? We’re ready to help.
InnoStrat Welcomes Malte Clausen as Senior Partner
20 June 2025
InnoStrat expands its leadership team with the appointment of Malte Clausen as Senior Partner. With more than two decades of experience across pharma, life sciences, and energy — including senior roles at McKinsey and BCG — Malte brings strategic clarity and transformation expertise to support InnoStrat’s continued growth.
InnoStrat Expands Board of Directors to Strengthen Global Growth
11 March 2025
As InnoStrat continues to expand internationally, we are pleased to announce the addition of three highly experienced professionals to our Board of Directors. With deep expertise in biopharma innovation, strategy, and corporate development, they will play a key role in driving our continued growth and delivering even greater value to our clients.
Engaging with Clients Across Switzerland
17 February 2025
Last week, we connected with clients in Zurich, Zug, and Bern, engaging in strategic discussions with big pharma, mid-sized companies, and biotech firms. Our expertise spans RWE, Medical Affairs, and commercial functions across various therapy areas, including oncology and rare diseases.
Reflecting on 2024 & Looking Ahead to 2025
20 December 2024
2024 was a year of growth, new challenges, and exciting milestones for InnoStrat. As we move into 2025, we remain dedicated to helping life-science companies elevate Medical Affairs and implement innovation.
Welcoming Louise Kristensen to InnoStrat
2 December 2024
We are thrilled to welcome Louise Kristensen as a Consultant! With a strong background in pharmaceutical design and engineering, she will play a key role in advancing our data-driven solutions for life sciences.
Driving Medical Excellence with a Clear Roadmap
27 November 2024
InnoStrat facilitated workshops to develop a tailored medical roadmap for a mid-sized pharma company, focusing on KOL engagement, publication strategies, and communication consistency across global markets.
Maria Lajer Joins InnoStrat as Senior Consultant
3 November 2024
We’re excited to announce Maria Lajer as our new Senior Consultant! With over 20 years of experience in RWE and Medical Affairs, she brings invaluable expertise in evidence planning and strategic medical initiatives.
Successful Patient Recruitment in a Competitive Phase 2b Trial
11 October 2024
InnoStrat supported a mid-sized pharma company in achieving timely patient recruitment for a competitive phase 2b trial. Our tailored engagement programs strengthened KOL relationships, enhanced protocol adherence, and laid the groundwork for a successful phase 3a program.
22 September 2024
InnoStrat’s investigator and study coordinator panels are transforming clinical trials. A recent event in Berlin showcased our innovative approach to improving patient recruitment and advancing scientific collaboration.
Welcoming Henrik Schou as a Partner
31 August 2024
We’re pleased to welcome Henrik Schou as our new Partner! With extensive experience in market access, pricing, and evidence generation, he will strengthen our ability to support pharma companies worldwide.
Strategic Evidence Generation for Product Launches
13 August 2024
InnoStrat helped a mid-sized pharma company refine its RWE strategy by engaging 20 affiliates to prioritize local evidence gaps. Our structured approach ensures efficient resource allocation and maximized impact for successful global product launches.
Let’s explore what’s possible
Whether you’re building a medical affairs team, planning a product launch, or looking to strengthen your clinical trial performance — we’re ready to help.
Contact us to learn how InnoStrat can support your next step.
